Biocodex
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
5
Ending by 2030
Nov 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Jul 7 to 26, 2027 · next Jul 7
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,569,565 | Pharmaceutical composition for the prevention or treatment of cerebral oedemas In force · From the USPTO record | In force | From the USPTO record | |
| US 8,093,381 | Method of synthesis of fluoroquinolones In force · From the USPTO record | In force | From the USPTO record | |
| US 7,750,169 | Process for the preparation of stiripentol particles having a defined particle size distribution In force · From the USPTO record | In force | From the USPTO record | |
| US 10,675,266 | Compounds and methods for treating autism spectrum disorders In force · From the USPTO record | In force | From the USPTO record | |
| US 8,338,410 | Neuroprotective compounds and pharmaceutical compositions comprising them In force · From the USPTO record | In force | From the USPTO record | |
| US 8,575,211 | Synergistic combination of analgesic compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 8,598,221 | Synergistic combination of analgesic compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 9,241,961 | Medicinal product for treating gastrointestinal ulcers In force · From the USPTO record | In force | From the USPTO record | |
| US 8,927,600 | Compound for use in the treatment of peripheral neuropathies In force · From the USPTO record | In force | From the USPTO record | |
| US 10,696,647 | Pharmacological treatment of obsessive-compulsive disorder In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 13: 2 patents in force now held by others · 1 lapsed for an unpaid fee · 4 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 1 abandoned · 6 no status recorded